The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...

The investment will fund a new drug manufacturing facility in Virginia, and expand research and development in at least 5 ...

The pharmaceutical industry’s move toward increased U.S.-based manufacturing is changing the landscape of career ...

Gov. Glenn Youngkin says he has a deal for a multi-billion-dollar pharmaceutical factory in Virginia, but he doesn't have a ...

With a mega investment of 50 billion dollars, Astrazeneca has plans to expand its presence in medicines manufacturing and R&D ...

AstraZeneca, a pharmaceutical company, has announced its plans to bring a drug substance manufacturing facility to Virginia.

Phlow’s capital raise announcement came a day after Gov. Glenn Youngkin and British pharmaceutical firm AstraZeneca publicly ...

AstraZeneca has increased its investment in U.S. operations more than 14-fold, committing $50 billion to a range of ...

AstraZeneca said it was investing €300m to establish a next-generation active pharmaceutical ingredient (API) manufacturing ...

Treasury Secretary Scott Bessent offered support for Jerome Powell amid regular attacks from Trump administration officials, ...

AstraZeneca is investing $50 billion in U.S. manufacturing and research by 2030, with a focus on producing drug substances for chronic disease treatments. The main element of the investment is a ...

NEW YORK (AP) — Amid a federal overhaul of student loan plans, many borrowers have been left wondering what it means for ...